Genetic Analysis AS presentation from Aktieportföljen Live

OSLO, NORWAY - 27 August 2021: Genetic Analysis presented the business, the company's future plans, and IPO at Aktieportföljen Live. The presentation is now available.

Genetic Analysis CEO Ronny Hermansen and CCO Anita Patel Jusnes presented the business and the company’s IPO at Aktieportföljen Live. You can find the presentation on Genetic Analysis website.

For further information, please contact:

Ronny Hermansen, CEO
E-mail: rh@genetic-analysis.com

About Genetic Analysis 

Genetic Analysis AS (GA) is a science-based diagnostic company and pioneer in the human microbiome field with more than 10 years of expertise in research and product development.  The unique GA-map® platform is based on a pre-targeted multiplex approach specialized for simultaneous analysis of a large number of bacteria in one reaction. The test results are generated by utilizing the clinically validated cutting edge GA-map® software algorithm. This enables immediate results without the need of further bioinformatics work. GA’s vision is to become the leading company for standardized gut microbiota testing worldwide, and GA is committed to help unlocking and restoring the human microbiome through its state-of-the-art technology. GA holds 22 highly qualified employees with relevant scientific backgrounds and with competence in bioinformatics, molecular biology, and bioengineering. www.genetic-analysis.com